February 20, 2013
When Is Less Surgery Beneficial in Breast Cancer?
Dr. Lidia Schapira, of Harvard Medical School and Massachusetts General Hospital, spoke to the Mayo Clinic’s Judy C. Boughey, MD, about the ACOSOG Z1071 trial, which looked at whether patients who had axillary lymph node involvement before neoadjuvant chemotherapy and who had a good response to systemic therapy could avoid axillary lymph node dissection. The […]
Tags: axillary lymph node dissection, Dr. Judy Boughey, Dr. Lidia Schapira, Harvard Medical School, Massachusetts General Hospital, Medscape, San Antonio Breast Cancer Symposium, systemic therapy
February 1, 2012
Pulse on Health: For whom do experts speak?
Two physicians, one from the University of Pennsylvania and one from Massachusetts General Hospital, wrote a New York Times opinion piece criticizing Mayo Clinic for investing in proton therapy to treat cancer. I called to see if plans to publish potentially controversial opinions were shared internally beforehand, because a source suggested their employers were caught […]
Tags: Massachusetts General Hospital, New York Times, proton therapy, University of Pennsylvania